ESSA Pharma to Participate in the Guggenheim Healthcare Talks 5th Annual Oncology Conference

ESSA Pharma Inc. (NASDAQ: EPIX) announced its participation in a fireside chat at the Guggenheim Healthcare Talks 5th Annual Oncology Conference on February 9, 2023, at 9:00 a.m. Eastern Time in New York City.

Rhea-AI Summary

ESSA Pharma Inc. (NASDAQ: EPIX) announced its participation in a fireside chat at the Guggenheim Healthcare Talks 5th Annual Oncology Conference on February 9, 2023, at 9:00 a.m. Eastern Time in New York City. Key executives, including President and CEO David R. Parkinson, will also hold one-on-one meetings. A live webcast of the presentation will be available on ESSA's website, with an archived replay accessible for 30 days after the event. ESSA focuses on developing novel therapies for prostate cancer, aiming to provide innovative treatment solutions for patients.

Argus Session date unavailable

+0.34% session move Open Argus

Details

News Market Reaction – EPIX

The recorded move for EPIX in the trading session of this news was +0.34%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SOUTH SAN FRANCISCO, California and VANCOUVER, Canada, Feb. 2, 2023 /PRNewswire/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today announced that the Company will participate in a fireside chat at the Guggenheim Healthcare Talks 5th Annual Oncology Conference in New York City on Thursday, February 9, 2023, at 9:00 a.m. Eastern Time.

David R. Parkinson, President and Chief Executive Officer of ESSA Pharma; Peter Virsik, ESSA's Chief Operating Officer; and David S. Wood, ESSA's Chief Financial Officer, will host and participate in one-on-one meetings.

A live webcast of the presentation can be accessed in the Investors/Events & Presentations section of ESSA's website at www.essapharma.com. An archived replay of the event will be available for 30 days.

About ESSA Pharma Inc.

ESSA is a clinical-stage pharmaceutical company focused on developing novel and proprietary therapies for the treatment of patients with prostate cancer. For more information, please visit www.essapharma.com and follow us on Twitter under @ESSAPharma.

View original content:https://www.prnewswire.com/news-releases/essa-pharma-to-participate-in-the-guggenheim-healthcare-talks-5th-annual-oncology-conference-301737785.html

SOURCE ESSA Pharma Inc

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What is ESSA Pharma's participation in the Guggenheim Healthcare Talks 5th Annual Oncology Conference?

ESSA Pharma will participate in a fireside chat at the conference on February 9, 2023, at 9:00 a.m. Eastern Time in New York City.

Who are the key executives representing ESSA Pharma at the conference?

Key executives include David R. Parkinson, President and CEO; Peter Virsik, Chief Operating Officer; and David S. Wood, Chief Financial Officer.

Where can I access the live webcast of ESSA Pharma's presentation?

The live webcast can be accessed on ESSA Pharma's website in the Investors/Events & Presentations section.

How long will the archived replay of ESSA Pharma's conference presentation be available?

The archived replay will be available for 30 days after the event.

What is the focus of ESSA Pharma's research and development?

ESSA Pharma focuses on developing novel and proprietary therapies for the treatment of prostate cancer.